The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals
- PMID: 2546314
- DOI: 10.1007/BF00256245
The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals
Abstract
The addition of different amounts of hydroxyapatite crystals (HAP) to a solution, metastably supersaturated with respect to calcium oxalate (CaOx) resulted in heterogenous crystallization at seed concentrations exceeding 0.2 mmol/l. The induction period varied between 1 and more than 8 h with the shortest period for a seed concentration of 2 mmol/l. Addition to the system of 1 and 2% of whole urine and citrate in concentrations corresponding to approximately 1% of that found in normal urine inhibited the crystallization for as long as 4 h. In a system supersaturated with respect to calcium phosphate (CaP) the total number of crystals was markedly reduced by citrate concentrations exceeding 0.5 mmol/l. The fractions of medium sized and large crystals were sharply reduced and small crystals predominated at higher citrate concentrations. This might indicate effects of citrate on both crystal growth and crystal aggregation. We conclude that increased citrate concentrations during treatment with alkali leads to a significant inhibition of CaOx growth on HAP as well as to a prevention of the formation of large CaP crystals from solutions supersaturated with respect to CaP.
Similar articles
-
Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.Urol Res. 1999 Apr;27(2):117-26. doi: 10.1007/s002400050097. Urol Res. 1999. PMID: 10424393 Clinical Trial.
-
Alkaline citrate in prevention of recurrent calcium oxalate stones.Scand J Urol Nephrol Suppl. 1990;130:1-83. Scand J Urol Nephrol Suppl. 1990. PMID: 2291093
-
Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules.Urol Res. 1999 Dec;27(6):417-25. doi: 10.1007/s002400050130. Urol Res. 1999. PMID: 10651129
-
Effects of citrate on the different phases of calcium oxalate crystallization.Scanning Microsc. 1993 Mar;7(1):381-9; discussion 389-90. Scanning Microsc. 1993. PMID: 8316807 Review.
-
Glycoprotein calcium oxalate crystal growth inhibitor in urine.Miner Electrolyte Metab. 1987;13(4):267-72. Miner Electrolyte Metab. 1987. PMID: 3306319 Review.
Cited by
-
Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation?Urol Res. 1993 May;21(3):175-80. doi: 10.1007/BF00590033. Urol Res. 1993. PMID: 8342251
-
Citrate and urease-induced crystallization in synthetic and human urine.Urol Res. 1993 Mar;21(2):109-15. doi: 10.1007/BF01788828. Urol Res. 1993. PMID: 8503146
-
Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.Urol Res. 1997;25(2):153-9. doi: 10.1007/BF01037933. Urol Res. 1997. PMID: 9144885
-
Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.Urol Res. 2009 Aug;37(4):181-92. doi: 10.1007/s00240-009-0191-7. Epub 2009 May 15. Urol Res. 2009. PMID: 19444436
-
Intratubular crystallization events.World J Urol. 1997;15(4):219-28. doi: 10.1007/BF01367659. World J Urol. 1997. PMID: 9280050 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous